Go to deals
Food & Beverage

Greenyard has successfully strengthened its capital structure

Alychlo NV, an investment company controlled by Mr Marc Coucke, as well as the existing shareholder, Mr Joris Ide, have committed to participate in a US$60 million reserved capital increase.

Greenyard (Euronext Brussels: GREEN) is a global market leader of fresh, frozen and prepared fruit and vegetables, flowers and plants. Counting Europe’s leading retailers amongst its customer base, Greenyard provides efficient and sustainable solutions to customers and suppliers through best-in-class products, market leading innovation, operational excellence and outstanding service. The company’s vision is to make lives healthier by helping people enjoy fruit and vegetables at any moment, easily, quickly and pleasurably, whilst fostering nature. With approximately 9,000 employees operating in 23 countries worldwide, Greenyard identifies its people, and customer and supplier relationships, as the key assets which enable it to deliver goods and services worth around US$4.8 billion per annum.

Oaklins’ team in Belgium advised Greenyard and acted as joint global coordinator and joint bookrunner in this transaction.

Talk to the deal team

Thomas Roelens

Managing Director
Brussels, Belgium
Oaklins KBC Securities

Related deals

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Construction & Engineering Services

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland

Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.

Learn more
Duke Capital Limited has completed a fundraising
Financial Services

Duke Capital Limited has completed a fundraising

Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more